{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:29:00Z","timestamp":1786980540733,"version":"build-2736575974"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s10072-025-08370-w","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T22:05:44Z","timestamp":1754345144000},"page":"4805-4818","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Metformin as a potential neuroprotective agent that influence Parkinson\u2019s disease"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-6299-4871","authenticated-orcid":false,"given":"Bhaskar","family":"Pal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niladri","family":"Ghatak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5283-7297","authenticated-orcid":false,"given":"Chowdhury Mobaswar","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,4]]},"reference":[{"issue":"s1","key":"8370_CR1","first-page":"S3","volume":"8","author":"ER Dorsey","year":"2018","unstructured":"Dorsey ER, Sherer T, Okun MS, Bloem BR (2018) The emerging evidence of the Parkinson pandemic. J Park Dis 8(s1):S3\u2013S8","journal-title":"J Park Dis"},{"issue":"6","key":"8370_CR2","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1007\/s13760-020-01473-5","volume":"120","author":"A Cherian","year":"2020","unstructured":"Cherian A, Divya KP (2020) Genetics of Parkinson\u2019s disease. Acta Neurol Belg 120(6):1297\u20131305","journal-title":"Acta Neurol Belg"},{"issue":"830","key":"8370_CR3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ejphar.2018.04.023","volume":"5","author":"AK Kakkar","year":"2018","unstructured":"Kakkar AK, Singh H, Medhi B (2018) Old wines in new bottles: repurposing opportunities for Parkinson\u2019s disease. Eur J Pharmacol 5(830):115\u2013127","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"8370_CR4","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nm.2165","volume":"16","author":"JA Obeso","year":"2010","unstructured":"Obeso JA, Rodriguez-Oroz MC, Goetz CG, Marin C, Kordower JH, Rodriguez M et al (2010) Missing pieces in the Parkinson\u2019s disease puzzle. Nat Med 16(6):653\u2013661","journal-title":"Nat Med"},{"issue":"1","key":"8370_CR5","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40035-017-0099-z","volume":"6","author":"P Maiti","year":"2017","unstructured":"Maiti P, Manna J, Dunbar GL (2017) Current understanding of the molecular mechanisms in Parkinson\u2019s disease: targets for potential treatments. Transl Neurodegener 6(1):28","journal-title":"Transl Neurodegener"},{"issue":"11","key":"8370_CR6","doi-asserted-by":"publisher","first-page":"8754","DOI":"10.1007\/s12035-018-1025-9","volume":"55","author":"A Biosa","year":"2018","unstructured":"Biosa A, Outeiro TF, Bubacco L, Bisaglia M (2018) Diabetes mellitus as a risk factor for Parkinson\u2019s disease: a molecular point of view. Mol Neurobiol 55(11):8754\u20138763","journal-title":"Mol Neurobiol"},{"key":"8370_CR7","doi-asserted-by":"publisher","first-page":"204201882098022","DOI":"10.1177\/2042018820980225","volume":"12","author":"C Baker","year":"2021","unstructured":"Baker C, Retzik-Stahr C, Singh V, Plomondon R, Anderson V, Rasouli N (2021) Should metformin remain the first-line therapy for treatment of type 2 diabetes? Ther Adv Endocrinol Metab 12:2042018820980225","journal-title":"Ther Adv Endocrinol Metab"},{"key":"8370_CR8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3389\/fendo.2020.00191","volume":"11","author":"Z Lv","year":"2020","unstructured":"Lv Z, Guo Y (2020) Metformin and its benefits for various diseases. Front Endocrinol 11:191","journal-title":"Front Endocrinol"},{"issue":"8","key":"8370_CR9","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/jnnp-2019-322338","volume":"91","author":"J Jankovic","year":"2020","unstructured":"Jankovic J, Tan EK (2020) Parkinson\u2019s disease: etiopathogenesis and treatment. J Neurol Neurosurg Psychiatry 91(8):795\u2013808","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"8370_CR10","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1002\/mds.27823","volume":"34","author":"YC Wong","year":"2019","unstructured":"Wong YC, Luk K, Purtell K, Burke Nanni S, Stoessl AJ, Trudeau LE et al (2019) Neuronal vulnerability in Parkinson disease: should the focus be on axons and synaptic terminals? Mov Disord Off J Mov Disord Soc 34(10):1406\u20131422","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"8370_CR11","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3389\/fneur.2018.00455","volume":"9","author":"N Gigu\u00e8re","year":"2018","unstructured":"Gigu\u00e8re N, Burke Nanni S, Trudeau LE (2018) On cell loss and selective vulnerability of neuronal populations in Parkinson\u2019s disease. Front Neurol 9:455","journal-title":"Front Neurol"},{"issue":"1","key":"8370_CR12","first-page":"27","volume":"3","author":"M Lu","year":"2020","unstructured":"Lu M, Chen H, Nie F, Wei X, Tao Z, Ma J (2020) The potential role of metformin in the treatment of Parkinson\u2019s disease. J Bio-X Res 3(1):27\u201335","journal-title":"J Bio-X Res"},{"issue":"1","key":"8370_CR13","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/nm.3983","volume":"22","author":"W Wang","year":"2016","unstructured":"Wang W, Wang X, Fujioka H, Hoppel C, Whone AL, Caldwell MA et al (2016) Parkinson\u2019s disease-associated mutant VPS35 causes mitochondrial dysfunction by recycling DLP1 complexes. Nat Med 22(1):54\u201363","journal-title":"Nat Med"},{"key":"8370_CR14","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/978-3-031-66421-2_12","volume-title":"Role of autophagy and reactive oxygen species in cancer treatment: principles and current strategies","author":"M Chattopadhyay","year":"2024","unstructured":"Chattopadhyay M, Chanda A, Pal B (2024) Unravelling the nexus: mitochondrial oxidative stress, tumour microenvironment, and escape from immune surveillance. Role of autophagy and reactive oxygen species in cancer treatment: principles and current strategies. Cham Springer, Nature Switzerland, pp 255\u2013286"},{"issue":"3","key":"8370_CR15","doi-asserted-by":"publisher","first-page":"171","DOI":"10.5607\/en.2018.27.3.171","volume":"27","author":"DH Ho","year":"2018","unstructured":"Ho DH, Je AR, Lee H, Son I, Kweon HS, Kim HG et al (2018) LRRK2 kinase activity induces mitochondrial fission in microglia via drp1 and modulates neuroinflammation. Exp Neurobiol 27(3):171\u2013180","journal-title":"Exp Neurobiol"},{"issue":"9","key":"8370_CR16","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1038\/nprot.2014.143","volume":"9","author":"LA Volpicelli-Daley","year":"2014","unstructured":"Volpicelli-Daley LA, Luk KC, Lee VMY (2014) Addition of exogenous \u03b1-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous \u03b1-synuclein to Lewy body and Lewy neurite-like aggregates. Nat Protoc 9(9):2135\u20132146","journal-title":"Nat Protoc"},{"issue":"328","key":"8370_CR17","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.bbr.2017.04.028","volume":"15","author":"CLC Camp\u00ealo","year":"2017","unstructured":"Camp\u00ealo CLC, Santos JR, Silva AF, Dierschnabel AL, Pontes A, Cavalcante JS et al (2017) Exposure to an enriched environment facilitates motor recovery and prevents short-term memory impairment and reduction of striatal BDNF in a progressive pharmacological model of parkinsonism in mice. Behav Brain Res 15(328):138\u2013148","journal-title":"Behav Brain Res"},{"issue":"1","key":"8370_CR18","first-page":"38","volume":"51","author":"F Zhu","year":"2019","unstructured":"Zhu F, Li C, Gong J, Zhu W, Gu L, Li N (2019) The risk of Parkinson\u2019s disease in inflammatory bowel disease: a systematic review and meta-analysis. Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver 51(1):38\u201342","journal-title":"Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver"},{"key":"8370_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.clnesp.2017.03.006","volume":"20","author":"AO Schelp","year":"2017","unstructured":"Schelp AO, Mendes-Chiloff CL, Paduan VC, Corrente JE, Vieira A, Marchette JCN et al (2017) Amnestic dementia impairment in Parkinson\u2019s disease: the role of body composition, ageing and insulin resistance. Clin Nutr ESPEN 20:47\u201351","journal-title":"Clin Nutr ESPEN"},{"issue":"6","key":"8370_CR20","first-page":"1132","volume":"33","author":"M Vikdahl","year":"2014","unstructured":"Vikdahl M, Carlsson M, Linder J, Forsgren L, H\u00e5glin L (2014) Weight gain and increased central obesity in the early phase of Parkinson\u2019s disease. Clin Nutr Edinb Scotl 33(6):1132\u20131139","journal-title":"Clin Nutr Edinb Scotl"},{"issue":"1\u20132","key":"8370_CR21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jns.2011.12.008","volume":"315","author":"D Bosco","year":"2012","unstructured":"Bosco D, Plastino M, Cristiano D, Colica C, Ermio C, De Bartolo M et al (2012) Dementia is associated with insulin resistance in patients with Parkinson\u2019s disease. J Neurol Sci 315(1\u20132):39\u201343","journal-title":"J Neurol Sci"},{"issue":"5","key":"8370_CR22","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.drudis.2016.01.013","volume":"21","author":"D Athauda","year":"2016","unstructured":"Athauda D, Foltynie T (2016) The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson\u2019s disease: mechanisms of action. Drug Discov Today 21(5):802\u2013818","journal-title":"Drug Discov Today"},{"issue":"12","key":"8370_CR23","doi-asserted-by":"publisher","first-page":"732","DOI":"10.3389\/fnins.2018.00732","volume":"10","author":"BA L\u00e1z\u00e1r","year":"2018","unstructured":"L\u00e1z\u00e1r BA, Jancs\u00f3 G, P\u00e1lv\u00f6lgyi L, Dobos I, Nagy I, S\u00e1ntha P (2018) Insulin confers differing effects on neurite outgrowth in separate populations of cultured dorsal root ganglion neurons: the role of the insulin receptor. Front Neurosci 10(12):732","journal-title":"Front Neurosci"},{"issue":"11","key":"8370_CR24","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.1073\/pnas.1500877112","volume":"112","author":"A Kleinridders","year":"2015","unstructured":"Kleinridders A, Cai W, Cappellucci L, Ghazarian A, Collins WR, Vienberg SG et al (2015) Insulin resistance in brain alters dopamine turnover and causes behavioral disorders. Proc Natl Acad Sci U S A 112(11):3463\u20133468","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"8370_CR25","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.neulet.2012.01.077","volume":"513","author":"X Gong","year":"2012","unstructured":"Gong X, Ma M, Fan X, Li M, Liu Q, Liu X et al (2012) Down-regulation of IGF-1\/IGF-1R in hippocampus of rats with vascular dementia. Neurosci Lett 513(1):20\u201324","journal-title":"Neurosci Lett"},{"issue":"1","key":"8370_CR26","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.neulet.2009.09.055","volume":"467","author":"S Timmons","year":"2009","unstructured":"Timmons S, Coakley MF, Moloney AM, O\u2019Neill C (2009) Akt signal transduction dysfunction in Parkinson\u2019s disease. Neurosci Lett 467(1):30\u201335","journal-title":"Neurosci Lett"},{"key":"8370_CR27","first-page":"1","volume":"5","author":"B Pal","year":"2024","unstructured":"Pal B, Ghosh R, Sarkar RD, Roy GS (2024) The irreversible, towards fatalic neuropathy: from the genesis of diabetes. Acta Diabetol 5:1\u20138","journal-title":"Acta Diabetol"},{"key":"8370_CR28","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.pneurobio.2016.10.001","volume":"145\u2013146","author":"D Athauda","year":"2016","unstructured":"Athauda D, Foltynie T (2016) Insulin resistance and Parkinson\u2019s disease: a new target for disease modification? Prog Neurobiol 145\u2013146:98\u2013120","journal-title":"Prog Neurobiol"},{"issue":"218","key":"8370_CR29","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.lfs.2018.12.029","volume":"1","author":"HA Elfawy","year":"2019","unstructured":"Elfawy HA, Das B (2019) Crosstalk between mitochondrial dysfunction, oxidative stress, and age related neurodegenerative disease: etiologies and therapeutic strategies. Life Sci 1(218):165\u2013184","journal-title":"Life Sci"},{"issue":"3","key":"8370_CR30","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.tics.2018.12.006","volume":"23","author":"T Ott","year":"2019","unstructured":"Ott T, Nieder A (2019) Dopamine and cognitive control in prefrontal cortex. Trends Cogn Sci 23(3):213\u2013234","journal-title":"Trends Cogn Sci"},{"issue":"190","key":"8370_CR31","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.neuroimage.2018.11.021","volume":"15","author":"D Meder","year":"2019","unstructured":"Meder D, Herz DM, Rowe JB, Leh\u00e9ricy S, Siebner HR (2019) The role of dopamine in the brain - lessons learned from Parkinson\u2019s disease. Neuroimage 15(190):79\u201393","journal-title":"Neuroimage"},{"key":"8370_CR32","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.biopha.2018.12.101","volume":"111","author":"SH Tan","year":"2019","unstructured":"Tan SH, Karri V, Tay NWR, Chang KH, Ah HY, Ng PQ et al (2019) Emerging pathways to neurodegeneration: dissecting the critical molecular mechanisms in Alzheimer\u2019s disease, Parkinson\u2019s disease. Biomed Pharmacother Biomedecine Pharmacother 111:765\u2013777","journal-title":"Biomed Pharmacother Biomedecine Pharmacother"},{"issue":"5","key":"8370_CR33","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.1007\/s12035-015-9274-3","volume":"53","author":"SP Gupta","year":"2016","unstructured":"Gupta SP, Kamal R, Mishra SK, Singh MK, Shukla R, Singh MP (2016) Association of polymorphism of neuronal nitric oxide synthase gene with risk to Parkinson\u2019s disease. Mol Neurobiol 53(5):3309\u20133314","journal-title":"Mol Neurobiol"},{"issue":"7","key":"8370_CR34","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.bbadis.2008.12.006","volume":"1792","author":"AHK Tsang","year":"2009","unstructured":"Tsang AHK, Chung KKK (2009) Oxidative and nitrosative stress in Parkinson\u2019s disease. Biochim Biophys Acta 1792(7):643\u2013650","journal-title":"Biochim Biophys Acta"},{"key":"8370_CR35","doi-asserted-by":"crossref","unstructured":"Domingueti CP, Dusse LMS, Carvalho M das G, de Sousa LP, Gomes KB, Fernandes AP (2016) Diabetes mellitus: the linkage between oxidative stress, inflammation, hypercoagulability and vascular complications. J Diabetes Complications 30(4): 738-745","DOI":"10.1016\/j.jdiacomp.2015.12.018"},{"issue":"Suppl 1","key":"8370_CR36","doi-asserted-by":"publisher","first-page":"S207","DOI":"10.1016\/S1353-8020(11)70064-5","volume":"18","author":"S Phani","year":"2012","unstructured":"Phani S, Loike JD, Przedborski S (2012) Neurodegeneration and inflammation in Parkinson\u2019s disease. Parkinsonism Relat Disord 18(Suppl 1):S207-209","journal-title":"Parkinsonism Relat Disord"},{"issue":"299","key":"8370_CR37","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.toxlet.2018.09.015","volume":"15","author":"EN Dover","year":"2018","unstructured":"Dover EN, Patel NY, St\u00fdblo M (2018) Impact of in vitro heavy metal exposure on pancreatic \u03b2-cell function. Toxicol Lett 15(299):137\u2013144","journal-title":"Toxicol Lett"},{"issue":"4","key":"8370_CR38","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/jmcb\/mjs025","volume":"4","author":"D Jain","year":"2012","unstructured":"Jain D, Jain R, Eberhard D, Eglinger J, Bugliani M, Piemonti L et al (2012) Age- and diet-dependent requirement of DJ-1 for glucose homeostasis in mice with implications for human type 2 diabetes. J Mol Cell Biol 4(4):221\u2013230","journal-title":"J Mol Cell Biol"},{"key":"8370_CR39","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.parkreldis.2018.08.023","volume":"64","author":"SJ Chung","year":"2019","unstructured":"Chung SJ, Jeon S, Yoo HS, Kim G, Oh JS, Kim JS et al (2019) Detrimental effect of type 2 diabetes mellitus in a large case series of Parkinson\u2019s disease. Parkinsonism Relat Disord 64:54\u201359","journal-title":"Parkinsonism Relat Disord"},{"issue":"377","key":"8370_CR40","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jns.2017.04.010","volume":"15","author":"M Ong","year":"2017","unstructured":"Ong M, Foo H, Chander RJ, Wen MC, Au WL, Sitoh YY et al (2017) Influence of diabetes mellitus on longitudinal atrophy and cognition in Parkinson\u2019s disease. J Neurol Sci 15(377):122\u2013126","journal-title":"J Neurol Sci"},{"issue":"12","key":"8370_CR41","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.parkreldis.2014.10.008","volume":"20","author":"NI Bohnen","year":"2014","unstructured":"Bohnen NI, Kotagal V, M\u00fcller MLTM, Koeppe RA, Scott PJH, Albin RL et al (2014) Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease. Parkinsonism Relat Disord 20(12):1394\u20131398","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"8370_CR42","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.parkreldis.2014.02.016","volume":"20","author":"M Giuntini","year":"2014","unstructured":"Giuntini M, Baldacci F, Del Prete E, Bonuccelli U, Ceravolo R (2014) Diabetes is associated with postural and cognitive domains in Parkinson\u2019s disease. Results from a single-center study. Parkinsonism Relat Disord 20(6):671\u2013672","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"8370_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/obr.12753","volume":"20","author":"Y Jia","year":"2019","unstructured":"Jia Y, Lao Y, Zhu H, Li N, Leung SW (2019) Is metformin still the most efficacious first-line oral hypoglycaemic drug in treating type 2 diabetes? A network meta-analysis of randomized controlled trials. Obes Rev Off J Int Assoc Study Obes 20(1):1\u201312","journal-title":"Obes Rev Off J Int Assoc Study Obes"},{"key":"8370_CR44","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.neures.2019.12.017","volume":"162","author":"N Saewanee","year":"2021","unstructured":"Saewanee N, Praputpittaya T, Malaiwong N, Chalorak P, Meemon K (2021) Neuroprotective effect of metformin on dopaminergic neurodegeneration and \u03b1-synuclein aggregation in C. elegans model of Parkinson\u2019s disease. Neurosci Res 162:13\u201321","journal-title":"Neurosci Res"},{"key":"8370_CR45","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.neuropharm.2017.08.015","volume":"125","author":"N Katila","year":"2017","unstructured":"Katila N, Bhurtel S, Shadfar S, Srivastav S, Neupane S, Ojha U et al (2017) Metformin lowers \u03b1-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson\u2019s disease. Neuropharmacology 125:396\u2013407","journal-title":"Neuropharmacology"},{"issue":"5","key":"8370_CR46","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1007\/s43440-020-00095-1","volume":"72","author":"G Ozbey","year":"2020","unstructured":"Ozbey G, Nemutlu-Samur D, Parlak H, Yildirim S, Aslan M, Tanriover G et al (2020) Metformin protects rotenone-induced dopaminergic neurodegeneration by reducing lipid peroxidation. Pharmacol Rep PR 72(5):1397\u20131406","journal-title":"Pharmacol Rep PR"},{"issue":"175","key":"8370_CR47","doi-asserted-by":"publisher","first-page":"108173","DOI":"10.1016\/j.neuropharm.2020.108173","volume":"15","author":"YK Ryu","year":"2020","unstructured":"Ryu YK, Go J, Park HY, Choi YK, Seo YJ, Choi JH et al (2020) Metformin regulates astrocyte reactivity in Parkinson\u2019s disease and normal aging. Neuropharmacology 15(175):108173","journal-title":"Neuropharmacology"},{"issue":"2","key":"8370_CR48","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.yexcr.2016.08.013","volume":"347","author":"MC Chiang","year":"2016","unstructured":"Chiang MC, Cheng YC, Chen SJ, Yen CH, Huang RN (2016) Metformin activation of AMPK-dependent pathways is neuroprotective in human neural stem cells against Amyloid-beta-induced mitochondrial dysfunction. Exp Cell Res 347(2):322\u2013331","journal-title":"Exp Cell Res"},{"key":"8370_CR49","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3389\/fncel.2018.00440","volume":"12","author":"K Tayara","year":"2018","unstructured":"Tayara K, Espinosa-Oliva AM, Garc\u00eda-Dom\u00ednguez I, Ismaiel AA, Boza-Serrano A, Deierborg T et al (2018) Divergent effects of metformin on an inflammatory model of Parkinson\u2019s disease. Front Cell Neurosci 12:440","journal-title":"Front Cell Neurosci"},{"issue":"6","key":"8370_CR50","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.molcel.2017.05.032","volume":"66","author":"D Garcia","year":"2017","unstructured":"Garcia D, Shaw RJ (2017) AMPK: mechanisms of cellular energy sensing and restoration of metabolic balance. Mol Cell 66(6):789\u2013800","journal-title":"Mol Cell"},{"issue":"8","key":"8370_CR51","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1111\/febs.16151","volume":"289","author":"R Muraleedharan","year":"2022","unstructured":"Muraleedharan R, Dasgupta B (2022) AMPK in the brain: its roles in glucose and neural metabolism. FEBS J 289(8):2247\u20132262","journal-title":"FEBS J"},{"issue":"25","key":"8370_CR52","first-page":"2186","volume":"25","author":"M Zhao","year":"2019","unstructured":"Zhao M, Li XW, Chen DZ, Hao F, Tao SX, Yu HY et al (2019) Neuro-protective role of metformin in patients with acute stroke and type 2 diabetes mellitus via AMPK\/mammalian target of rapamycin (mTOR) signaling pathway and oxidative stress. Med Sci Monit Int Med J Exp Clin Res 25(25):2186\u20132194","journal-title":"Med Sci Monit Int Med J Exp Clin Res"},{"key":"8370_CR53","doi-asserted-by":"publisher","first-page":"e31268","DOI":"10.7554\/eLife.31268","volume":"6","author":"J Chen","year":"2017","unstructured":"Chen J, Ou Y, Li Y, Hu S, Shao LW, Liu Y (2017) Metformin extends C elegans lifespan through lysosomal pathway. Elife 6:e31268","journal-title":"Elife"},{"issue":"107","key":"8370_CR54","first-page":"389","volume":"2016","author":"SE Sinnett","year":"2012","unstructured":"Sinnett SE, Brenman JE (2012) The role of AMPK in drosophila melanogaster. Exp Suppl 2016(107):389\u2013401","journal-title":"Exp Suppl"},{"key":"8370_CR55","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1038\/ncomms3192","volume":"4","author":"A Martin-Montalvo","year":"2013","unstructured":"Martin-Montalvo A, Mercken EM, Mitchell SJ, Palacios HH, Mote PL, Scheibye-Knudsen M et al (2013) Metformin improves healthspan and lifespan in mice. Nat Commun 4:2192","journal-title":"Nat Commun"},{"issue":"2","key":"8370_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nm.4269","volume":"23","author":"YC Wong","year":"2017","unstructured":"Wong YC, Krainc D (2017) \u03b1-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies. Nat Med 23(2):1\u201313","journal-title":"Nat Med"},{"issue":"5","key":"8370_CR57","doi-asserted-by":"publisher","first-page":"e1209","DOI":"10.1038\/cddis.2014.175","volume":"5","author":"BI P\u00e9rez-Revuelta","year":"2014","unstructured":"P\u00e9rez-Revuelta BI, Hettich MM, Ciociaro A, Rotermund C, Kahle PJ, Krauss S et al (2014) Metformin lowers Ser-129 phosphorylated \u03b1-synuclein levels via mTOR-dependent protein phosphatase 2A activation. Cell Death Dis 5(5):e1209","journal-title":"Cell Death Dis"},{"issue":"2","key":"8370_CR58","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1021\/acs.chemrestox.5b00497","volume":"29","author":"OR Kinsky","year":"2016","unstructured":"Kinsky OR, Hargraves TL, Anumol T, Jacobsen NE, Dai J, Snyder SA et al (2016) Metformin scavenges methylglyoxal to form a novel imidazolinone metabolite in humans. Chem Res Toxicol 29(2):227\u2013234","journal-title":"Chem Res Toxicol"},{"issue":"5","key":"8370_CR59","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1093\/brain\/awx056","volume":"140","author":"H Vicente Miranda","year":"2017","unstructured":"Vicente Miranda H, Szego \u00c9M, Oliveira LMA, Breda C, Darendelioglu E, de Oliveira RM et al (2017) Glycation potentiates \u03b1-synuclein-associated neurodegeneration in synucleinopathies. Brain J Neurol 140(5):1399\u20131419","journal-title":"Brain J Neurol"},{"key":"8370_CR60","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.conb.2019.11.008","volume":"61","author":"K Del Tredici","year":"2020","unstructured":"Del Tredici K, Braak H (2020) To stage, or not to stage. Curr Opin Neurobiol 61:10\u201322","journal-title":"Curr Opin Neurobiol"},{"issue":"2","key":"8370_CR61","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/imm.12922","volume":"154","author":"J Stephenson","year":"2018","unstructured":"Stephenson J, Nutma E, van der Valk P, Amor S (2018) Inflammation in CNS `3neurodegenerative diseases. Immunology 154(2):204\u2013219","journal-title":"Immunology"},{"issue":"175","key":"8370_CR62","doi-asserted-by":"publisher","first-page":"108173","DOI":"10.1016\/j.neuropharm.2020.108173","volume":"15","author":"YK Ryu","year":"2020","unstructured":"Ryu YK, Go J, Park HY, Choi YK, Seo YJ, Choi JH, Rhee M, Lee TG, Lee CH, Kim KS (2020) Metformin regulates astrocyte reactivity in Parkinson\u2019s disease and normal aging. Neuropharmacology 15(175):108173","journal-title":"Neuropharmacology"},{"issue":"12","key":"8370_CR63","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3389\/fncel.2018.00440","volume":"21","author":"K Tayara","year":"2018","unstructured":"Tayara K, Espinosa-Oliva AM, Garc\u00eda-Dom\u00ednguez I, Ismaiel AA, Boza-Serrano A, Deierborg T, Machado A, Herrera AJ, Venero JL, de Pablos RM (2018) Divergent effects of metformin on an inflammatory model of Parkinson\u2019s disease. Front Cell Neurosci 21(12):440","journal-title":"Front Cell Neurosci"},{"issue":"Pt 3","key":"8370_CR64","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1042\/bj3480607","volume":"348","author":"MR Owen","year":"2000","unstructured":"Owen MR, Doran E, Halestrap AP (2000) Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J 348(Pt 3):607\u2013614","journal-title":"Biochem J"},{"issue":"9","key":"8370_CR65","doi-asserted-by":"publisher","first-page":"753","DOI":"10.3389\/fendo.2018.00753","volume":"17","author":"E Fontaine","year":"2018","unstructured":"Fontaine E (2018) Metformin-induced mitochondrial complex I inhibition: facts, uncertainties, and consequences. Front Endocrinol 17(9):753","journal-title":"Front Endocrinol"},{"issue":"1","key":"8370_CR66","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1074\/jbc.275.1.223","volume":"275","author":"MY El-Mir","year":"2000","unstructured":"El-Mir MY, Nogueira V, Fontaine E, Av\u00e9ret N, Rigoulet M, Leverve X (2000) Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I. J Biol Chem 275(1):223\u2013228","journal-title":"J Biol Chem"},{"key":"8370_CR67","doi-asserted-by":"publisher","first-page":"102342","DOI":"10.1016\/j.redox.2022.102342","volume":"53","author":"AM Mara\u00f1\u00f3n","year":"2022","unstructured":"Mara\u00f1\u00f3n AM, D\u00edaz-Pozo P, Canet F, D\u00edaz-Morales N, Abad-Jim\u00e9nez Z, L\u00f3pez-Dom\u00e8nech S, Vezza T, Apostolova N, Morillas C, Rocha M, V\u00edctor VM (2022) Metformin modulates mitochondrial function and mitophagy in peripheral blood mononuclear cells from type 2 diabetic patients. Redox Biol 53:102342","journal-title":"Redox Biol"},{"issue":"5","key":"8370_CR68","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3390\/biology13050302","volume":"13","author":"E Amengual-Cladera","year":"2024","unstructured":"Amengual-Cladera E, Morla-Barcelo PM, Mor\u00e1n-Costoya A, Sastre-Serra J, Pons DG, Valle A, Roca P, Nadal-Serrano M (2024) Metformin: from diabetes to cancer\u2014unveiling molecular mechanisms and therapeutic strategies. Biology 13(5):302","journal-title":"Biology"},{"issue":"7","key":"8370_CR69","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.3390\/genes13071211","volume":"13","author":"SH Hong","year":"2022","unstructured":"Hong SH, Lee KS, Hwang HJ, Park SY, Han WK, Yoon YE (2022) Synergic effect of metformin and everolimus on mitochondrial dynamics of renal cell carcinoma. Genes 13(7):1211","journal-title":"Genes"},{"issue":"1","key":"8370_CR70","doi-asserted-by":"publisher","first-page":"398","DOI":"10.3390\/ijms23010398","volume":"23","author":"F Agostini","year":"2021","unstructured":"Agostini F, Masato A, Bubacco L, Bisaglia M (2021) Metformin repurposing for Parkinson disease therapy: opportunities and challenges. Int J Mol Sci 23(1):398","journal-title":"Int J Mol Sci"},{"issue":"12","key":"8370_CR71","doi-asserted-by":"publisher","first-page":"398","DOI":"10.3389\/fncel.2018.00398","volume":"6","author":"I Garc\u00eda-Dom\u00ednguez","year":"2018","unstructured":"Garc\u00eda-Dom\u00ednguez I, Vesel\u00e1 K, Garc\u00eda-Revilla J, Carrillo-Jim\u00e9nez A, Roca-Ceballos MA, Santiago M, de Pablos RM, Venero JL (2018) Peripheral inflammation enhances microglia response and Nigral dopaminergic cell death in an in vivo MPTP model of Parkinson\u2019s disease. Front Cell Neurosci 6(12):398","journal-title":"Front Cell Neurosci"},{"issue":"5","key":"8370_CR72","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1080\/15376516.2020.1741053","volume":"30","author":"DX Wang","year":"2020","unstructured":"Wang DX, Chen AD, Wang QJ, Xin YY, Yin J, Jing YH (2020) Protective effect of metformin against rotenone-induced Parkinsonism in mice. Toxicol Mech Methods 30(5):350\u2013357","journal-title":"Toxicol Mech Methods"},{"issue":"7886","key":"8370_CR73","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/s41586-021-04059-0","volume":"599","author":"P Gonz\u00e1lez-Rodr\u00edguez","year":"2021","unstructured":"Gonz\u00e1lez-Rodr\u00edguez P, Zampese E, Stout KA, Guzman JN, Ilijic E, Yang B, Tkatch T, Stavarache MA, Wokosin DL, Gao L, Kaplitt MG (2021) Disruption of mitochondrial complex I induces progressive Parkinsonism. Nature 599(7886):650\u2013656","journal-title":"Nature"},{"issue":"6","key":"8370_CR74","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/j.celrep.2019.09.070","volume":"29","author":"Y Wang","year":"2019","unstructured":"Wang Y, An H, Liu T, Qin C, Sesaki H, Guo S, Radovick S, Hussain M, Maheshwari A, Wondisford FE, O\u2019Rourke B, He L (2019) Metformin improves mitochondrial respiratory activity through activation of AMPK. Cell Rep 29(6):1511-1523.e5","journal-title":"Cell Rep"},{"key":"8370_CR75","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2165\/11534750-000000000-00000","volume":"50","author":"GG Graham","year":"2011","unstructured":"Graham GG, Punt J, Arora M, Day RO, Doogue MP, Duong J, Furlong TJ, Greenfield JR, Greenup LC, Kirkpatrick CM, Ray JE (2011) Clinical pharmacokinetics of metformin. Clin Pharmacokinet 50:81\u201398","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"8370_CR76","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.metabol.2015.10.014","volume":"65","author":"R DeFronzo","year":"2016","unstructured":"DeFronzo R, Fleming GA, Chen K, Bicsak TA (2016) Metformin-associated lactic acidosis: current perspectives on causes and risk. Metabolism 65(2):20\u201329","journal-title":"Metabolism"},{"issue":"4","key":"8370_CR77","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00401-019-02040-w","volume":"138","author":"N Van Den Berge","year":"2019","unstructured":"Van Den Berge N, Ferreira N, Gram H, Mikkelsen TW, Alstrup AKO, Casadei N et al (2019) Evidence for bidirectional and trans-synaptic parasympathetic and sympathetic propagation of alpha-synuclein in rats. Acta Neuropathol (Berl) 138(4):535\u2013550","journal-title":"Acta Neuropathol (Berl)"},{"issue":"1","key":"8370_CR78","doi-asserted-by":"publisher","first-page":"24","DOI":"10.4103\/jod.jod_117_23","volume":"15","author":"B Pal","year":"2024","unstructured":"Pal B, Chattopadhyay M (2024) Recent clinical and pharmacological advancements of incretin-based therapy and the effects of incretin on physiology. J Diabetology 15(1):24\u201337","journal-title":"J Diabetology"},{"issue":"9","key":"8370_CR79","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3389\/fendo.2018.00400","volume":"19","author":"C Rotermund","year":"2018","unstructured":"Rotermund C, Machetanz G, Fitzgerald JC (2018) The therapeutic potential of metformin in neurodegenerative diseases. Front Endocrinol 19(9):400","journal-title":"Front Endocrinol"},{"issue":"5","key":"8370_CR80","doi-asserted-by":"publisher","first-page":"588","DOI":"10.4103\/ijmr.IJMR_1572_16","volume":"145","author":"R Tripathi","year":"2017","unstructured":"Tripathi R, Tyagi S, Goel V (2017) Metformin in gestational diabetes mellitus. Indian J Med Res 145(5):588\u2013591","journal-title":"Indian J Med Res"},{"issue":"6","key":"8370_CR81","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.parkreldis.2012.03.010","volume":"18","author":"ML Wahlqvist","year":"2012","unstructured":"Wahlqvist ML, Lee MS, Hsu CC, Chuang SY, Lee JT, Tsai HN (2012) Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson\u2019s disease occurring with Type 2 diabetes in a Taiwanese population cohort. Parkinsonism Relat Disord 18(6):753\u2013758","journal-title":"Parkinsonism Relat Disord"},{"issue":"11","key":"8370_CR82","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1002\/mds.27128","volume":"32","author":"B Brakedal","year":"2017","unstructured":"Brakedal B, Fl\u00f8nes I, Reiter SF, Torkildsen \u00d8, D\u00f6lle C, Assmus J, Haugarvoll K, Tzoulis C (2017) Glitazone use associated with reduced risk of Parkinson\u2019s disease. Mov Disord 32(11):1594\u20131599","journal-title":"Mov Disord"},{"issue":"7","key":"8370_CR83","doi-asserted-by":"publisher","first-page":"e1001854","DOI":"10.1371\/journal.pmed.1001854","volume":"12","author":"R Brauer","year":"2015","unstructured":"Brauer R, Bhaskaran K, Chaturvedi N, Dexter DT, Smeeth L, Douglas I (2015) Glitazone treatment and incidence of Parkinson\u2019s disease among people with diabetes: a retrospective cohort study. PLoS Med 12(7):e1001854","journal-title":"PLoS Med"},{"issue":"18","key":"8370_CR84","doi-asserted-by":"publisher","first-page":"e3549","DOI":"10.1097\/MD.0000000000003549","volume":"95","author":"X Yue","year":"2016","unstructured":"Yue X, Li H, Yan H, Zhang P, Chang L, Li T (2016) Risk of Parkinson disease in diabetes mellitus: an updated meta-analysis of population-based cohort studies. Medicine (Baltimore) 95(18):e3549","journal-title":"Medicine (Baltimore)"},{"issue":"Pt B","key":"8370_CR85","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.pnpbp.2017.06.002","volume":"79","author":"YC Kuan","year":"2017","unstructured":"Kuan YC, Huang KW, Lin CL, Hu CJ, Kao CH (2017) Effects of metformin exposure on neurodegenerative diseases in elderly patients with type 2 diabetes mellitus. Prog Neuropsychopharmacol Biol Psychiatry 79(Pt B):77\u201383","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1\u20132","key":"8370_CR86","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jns.2011.12.008","volume":"315","author":"D Bosco","year":"2012","unstructured":"Bosco D, Plastino M, Cristiano D, Colica C, Ermio C, De Bartolo M, Mungari P, Fonte G, Consoli D, Consoli A, Fava A (2012) Dementia is associated with insulin resistance in patients with Parkinson\u2019s disease. J Neurol Sci 315(1\u20132):39\u201343","journal-title":"J Neurol Sci"},{"issue":"3","key":"8370_CR87","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3233\/JPD-191900","volume":"10","author":"JLY Cheong","year":"2020","unstructured":"Cheong JLY, de Pablo-Fernandez E, Foltynie T, Noyce AJ (2020) The association between type 2 diabetes mellitus and Parkinson\u2019s disease. J Parkinsons Dis 10(3):775\u2013789","journal-title":"J Parkinsons Dis"},{"issue":"1","key":"8370_CR88","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1210\/endrev\/bnaa023","volume":"42","author":"TE LaMoia","year":"2021","unstructured":"LaMoia TE, Shulman GI (2021) Cellular and molecular mechanisms of metformin action. Endocr Rev 42(1):77\u201396","journal-title":"Endocr Rev"},{"issue":"5","key":"8370_CR89","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S1734-1140(10)70357-1","volume":"62","author":"K \u0141abuzek","year":"2010","unstructured":"\u0141abuzek K, Suchy D, Gabryel B, Bielecka A, Liber S, Okopie\u0144 B (2010) Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide. Pharmacol Rep 62(5):956\u2013965","journal-title":"Pharmacol Rep"},{"key":"8370_CR90","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.brainresbull.2021.02.018","volume":"170","author":"A Thinnes","year":"2021","unstructured":"Thinnes A, Westenberger M, Piechotta C, Lehto A, Wirth F, Lau H, Klein J (2021) Cholinergic and metabolic effects of metformin in mouse brain. Brain Res Bull 170:211\u2013217","journal-title":"Brain Res Bull"},{"issue":"1444","key":"8370_CR91","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.brainres.2012.01.028","volume":"20","author":"WS Lv","year":"2012","unstructured":"Lv WS, Wen JP, Li L, Sun RX, Wang J, Xian YX, Cao CX, Wang YL, Gao YY (2012) The effect of metformin on food intake and its potential role in hypothalamic regulation in obese diabetic rats. Brain Res 20(1444):11\u201319","journal-title":"Brain Res"},{"issue":"12","key":"8370_CR92","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1007\/s11095-017-2199-y","volume":"34","author":"M Markowicz-Piasecka","year":"2017","unstructured":"Markowicz-Piasecka M, Sikora J, Szyd\u0142owska A, Skupie\u0144 A, Mikiciuk-Olasik E, Huttunen KM (2017) Metformin - a future therapy for neurodegenerative diseases\u202f: theme: drug discovery, development and delivery in Alzheimer\u2019s disease guest editor: Davide Brambilla. Pharm Res 34(12):2614\u20132627","journal-title":"Pharm Res"},{"issue":"4","key":"8370_CR93","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.bbrc.2013.03.036","volume":"433","author":"F Takata","year":"2013","unstructured":"Takata F, Dohgu S, Matsumoto J, Machida T, Kaneshima S, Matsuo M, Sakaguchi S, Takeshige Y, Yamauchi A, Kataoka Y (2013) Metformin induces up-regulation of blood-brain barrier functions by activating AMP-activated protein kinase in rat brain microvascular endothelial cells. Biochem Biophys Res Commun 433(4):586\u2013590","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"8370_CR94","first-page":"3351","volume":"8","author":"B Zhao","year":"2016","unstructured":"Zhao B, Wang X, Zheng J, Wang H, Liu J (2016) Effects of metformin treatment on glioma-induced brain edema. Am J Transl Res 8(8):3351\u20133363","journal-title":"Am J Transl Res"},{"key":"8370_CR95","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.redox.2017.02.007","volume":"12","author":"S Prasad","year":"2017","unstructured":"Prasad S, Sajja RK, Kaisar MA, Park JH, Villalba H, Liles T, Abbruscato T, Cucullo L (2017) Role of Nrf2 and protective effects of metformin against tobacco smoke-induced cerebrovascular toxicity. Redox Biol 12:58\u201369","journal-title":"Redox Biol"},{"key":"8370_CR96","doi-asserted-by":"publisher","first-page":"101665","DOI":"10.1016\/j.redox.2020.101665","volume":"36","author":"B Kalyanaraman","year":"2020","unstructured":"Kalyanaraman B (2020) Teaching the basics of repurposing mitochondria-targeted drugs: from Parkinson\u2019s disease to cancer and back to Parkinson\u2019s disease. Redox Biol 36:101665","journal-title":"Redox Biol"},{"issue":"5","key":"8370_CR97","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/aps.2012.188","volume":"34","author":"LQ He","year":"2013","unstructured":"He LQ, Lu JH, Yue ZY (2013) Autophagy in ageing and ageing-associated diseases. Acta Pharmacol Sin 34(5):605\u2013611","journal-title":"Acta Pharmacol Sin"},{"issue":"2","key":"8370_CR98","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1002\/jbm.b.34922","volume":"110","author":"BW Schlichtmann","year":"2022","unstructured":"Schlichtmann BW, Kalyanaraman B, Schlichtmann RL, Panthani MG, Anantharam V, Kanthasamy AG, Mallapragada SK, Narasimhan B (2022) Functionalized polyanhydride nanoparticles for improved treatment of mitochondrial dysfunction. J Biomed Mater Res B Appl Biomater 110(2):450\u2013459","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"8370_CR99","doi-asserted-by":"publisher","first-page":"114193","DOI":"10.1016\/j.bcp.2020.114193","volume":"180","author":"N Katila","year":"2020","unstructured":"Katila N, Bhurtel S, Park PH, Hong JT, Choi DY (2020) Activation of AMPK\/aPKC\u03b6\/CREB pathway by metformin is associated with upregulation of GDNF and dopamine. Biochem Pharmacol 180:114193","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"8370_CR100","doi-asserted-by":"publisher","first-page":"a008888","DOI":"10.1101\/cshperspect.a008888","volume":"2","author":"C Klein","year":"2012","unstructured":"Klein C, Westenberger A (2012) Genetics of Parkinson\u2019s disease. Cold Spring Harb Perspect Med 2(1):a008888","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"5","key":"8370_CR101","doi-asserted-by":"publisher","first-page":"949","DOI":"10.14336\/AD.2019.0120","volume":"10","author":"W Li","year":"2019","unstructured":"Li W, Chaudhari K, Shetty R, Winters A, Gao X, Hu Z, Ge WP, Sumien N, Forster M, Liu R, Yang SH (2019) Metformin alters locomotor and cognitive function and brain metabolism in normoglycemic mice. Aging Dis 10(5):949\u2013963","journal-title":"Aging Dis"},{"key":"8370_CR102","doi-asserted-by":"crossref","unstructured":"Scheen AJ (1996) Clinical pharmacokinetics of metformin. Clin Pharmacokinet 30(5):359\u2013371","DOI":"10.2165\/00003088-199630050-00003"},{"issue":"4","key":"8370_CR103","doi-asserted-by":"publisher","first-page":"202","DOI":"10.2337\/diaspect.19.4.202","volume":"19","author":"C Triplitt","year":"2006","unstructured":"Triplitt C (2006) Drug interactions of medications commonly used in diabetes. Diabetes Spectrum 19(4):202","journal-title":"Diabetes Spectrum"},{"key":"8370_CR104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40734-020-00085-8","volume":"7","author":"NS Luthra","year":"2020","unstructured":"Luthra NS, Marcus AH, Hills NK, Christine CW (2020) Vitamin B12 measurements across neurodegenerative disorders. J Clin Movement Disorders 7:1\u20136","journal-title":"J Clin Movement Disorders"},{"issue":"5","key":"8370_CR105","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1039\/C8FO02471E","volume":"10","author":"L Jia","year":"2019","unstructured":"Jia L, Wang Y, Wei W, Zhao W, Lu F, Liu F (2019) Vitamin B12 inhibits \u03b1-synuclein fibrillogenesis and protects against amyloid-induced cytotoxicity. Food Funct 10(5):2861\u20132870","journal-title":"Food Funct"},{"issue":"3","key":"8370_CR106","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/stem.3309","volume":"39","author":"T R\u00f5lova","year":"2021","unstructured":"R\u00f5lova T, Lehtonen \u0160, Goldsteins G, Kettunen P, Koistinaho J (2021) Metabolic and immune dysfunction of glia in neurodegenerative disorders: focus on iPSC models. Stem Cells 39(3):256\u2013265","journal-title":"Stem Cells"},{"issue":"12","key":"8370_CR107","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.3390\/cells9122623","volume":"9","author":"I Miyazaki","year":"2020","unstructured":"Miyazaki I, Asanuma M (2020) Neuron-astrocyte interactions in Parkinson\u2019s disease. Cells 9(12):2623","journal-title":"Cells"},{"issue":"1","key":"8370_CR108","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","volume":"9","author":"HS Kwon","year":"2020","unstructured":"Kwon HS, Koh SH (2020) Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes. Transl Neurodegener 9(1):42","journal-title":"Transl Neurodegener"},{"key":"8370_CR109","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.mam.2017.11.006","volume":"60","author":"T Croese","year":"2018","unstructured":"Croese T, Furlan R (2018) Extracellular vesicles in neurodegenerative diseases. Mol Aspects Med 60:52\u201361","journal-title":"Mol Aspects Med"},{"issue":"298","key":"8370_CR110","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.taap.2016.03.004","volume":"1","author":"AA Ismaiel","year":"2016","unstructured":"Ismaiel AA, Espinosa-Oliva AM, Santiago M, Garc\u00eda-Quintanilla A, Oliva-Mart\u00edn MJ, Herrera AJ, Venero JL, de Pablos RM (2016) Metformin, besides exhibiting strong in vivo anti-inflammatory properties, increases mptp-induced damage to the nigrostriatal dopaminergic system. Toxicol Appl Pharmacol 1(298):19\u201330","journal-title":"Toxicol Appl Pharmacol"},{"key":"8370_CR111","doi-asserted-by":"publisher","first-page":"105120","DOI":"10.1016\/j.neuint.2021.105120","volume":"148","author":"N Katila","year":"2021","unstructured":"Katila N, Bhurtel S, Park PH, Choi DY (2021) Metformin attenuates rotenone-induced oxidative stress and mitochondrial damage via the AKT\/Nrf2 pathway. Neurochem Int 148:105120","journal-title":"Neurochem Int"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08370-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-025-08370-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08370-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T08:21:50Z","timestamp":1759306910000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-025-08370-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,4]]},"references-count":111,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["8370"],"URL":"https:\/\/doi.org\/10.1007\/s10072-025-08370-w","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,4]]},"assertion":[{"value":"5 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No animal and human data was incorporated in the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent"}},{"value":"The authors declare that there is no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}